Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC): A case report

Lung Cancer

Volumn 51, Issue 2, 2006, Pages 257-259

  Subramanian, Janakiraman ^a   Pillot, Giancarlo ^b   Narra, Vamsidhar ^d   Govindan, Ramaswamy ^b,c,e  

^a ST LUKE S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Division of Oncology   (United States)

Author keywords

Bortezomib; Bronchiolo alveolar carcinoma; Non small cell lung cancer

Indexed keywords

BORTEZOMIB; CARBOPLATIN; GEFITINIB; GEMCITABINE; IMMUNOGLOBULIN; OXYGEN;

ADVANCED CANCER; AGED; ANAMNESIS; ANEMIA; ARTICLE; CANCER GROWTH; CASE REPORT; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG TOLERANCE; FOLLOW UP; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; HUMANS; LUNG NEOPLASMS; MALE; PYRAZINES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31344440016     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.10.007     Document Type: Article

References (10)

1. J.J. Laskin, A. Sandler, and D.H. Johnson Redefining bronchiolo-alveolar carcinoma Semin Oncol 32 3 2005 329 335
2. J.S. Ross, D.P. Schenkein, R. Pietrusko, M. Rolfe, G.P. Linette, and J. Stec Targeted therapies for cancer Am J Clin Pathol 122 4 2004 598 609
3. D. Schenkein Use of proteasome inhibition in the treatment of lung cancer Lung Cancer 6 S2 2004
4. A. Mani, and E.P. Gelmann The ubiquitin-proteasome pathway and its role in cancer J Clin Oncol 23 21 2005 4776 4789
5. P.G. Richardson A review of the proteasome inhibitor bortezomib in multiple myeloma Expert Opin Pharmacother 5 6 2004 1321 1331
6. J.W. McDonald, and T.K. Pilgram Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma Histopathology 34 1999 439 446
7. D. Ratschiller, J. Heighway, and M. Gugger Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival J Clin Oncol 21 11 2003 2085 2093
8. J.Q.X.J. Yuan, J. Zhang, Q.C. He, J. Zhu, and C.X. Sheng Expression and significance of cyclin D1, p27kip1 protein in bronchiolo-alveolar carcinoma J Zhejiang Univ Sci 5 2 2004 235 241
9. L.B.J. Kren, M. Hermanova, V.N. Goncharuk, B.V. Kallakury, P. Kaur, and J.S. Ross Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases Appl Immunohistochem Mol Morphol 12 1 2004 44 49
10. J. Zhao, T. Tenev, L. Martins, J. Downward, and N. Lemoine The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner J Cell Sci 113 23 2000 4363 4371